Taltz is used to treat certain autoimmune diseases. The FDA approved Taltz to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis. Taltz works by interfering with the activity of a signaling molecule (cytokine) called IL-17A, which is thought to play an important role in these diseases.